HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on Tough-to-Treat Hodgkin's lymphoma
Disease control Recruiting nowThis study is testing whether combining two existing drugs, pembrolizumab and azacitidine, can help control Hodgkin's lymphoma that has returned or hasn't responded to other treatments. It will measure how well the combination shrinks tumors and how safe it is for patients, inclu…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Tracking the hidden costs: how cancer treatments impact Women's bodies Long-Term
Knowledge-focused Recruiting nowThis study aims to understand how cancer treatments affect women's sexual function and ability to have children. Researchers will follow 475 women with breast cancer or lymphoma, collecting questionnaires and optional blood tests over time. The goal is to learn about these side e…
Matched conditions: HODGKIN'S LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC